News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Opinion|Videos|October 23, 2024 (Updated: October 23, 2024)

Managing Persistent MDD: Case Studies and Treatment Challenges

Key Takeaways

Gus Alva, MD, DFAPA presents the case of a patient with recurrent MDD, and the panel explores treatment approaches, comments on the condition triggers, and challenges in managing persistent depression.

Episodes in this series

EP. 1 Expert Insights into Navigating MDD Prevalence, Stigma, and Treatment Challenges for Improved Patient Outcomes

EP. 1 Expert Insights into Navigating MDD Prevalence, Stigma, and Treatment Challenges for Improved Patient Outcomes

EP. 2 Advancing MDD Treatment: From STAR*D Insights to Precision Medicine and Novel Therapeutics

EP. 2 Advancing MDD Treatment: From STAR*D Insights to Precision Medicine and Novel Therapeutics

EP. 3 Commentary on Redefining Depression Management with Updated Treatment Strategies

EP. 3 Commentary on Redefining Depression Management with Updated Treatment Strategies

EP. 4 Navigating Non-Response: A Holistic Approach to Patient Care

EP. 4 Navigating Non-Response: A Holistic Approach to Patient Care

EP. 5 Transforming MDD: A Patient's Journey with Rapid-Acting Therapy

EP. 5 Transforming MDD: A Patient's Journey with Rapid-Acting Therapy

EP. 6 Quantifying Success: Measuring Depth of Treatment Response in MDD

EP. 6 Quantifying Success: Measuring Depth of Treatment Response in MDD

EP. 7 Access Challenges: Bridging Insurance Gaps for MDD Innovations

EP. 7 Access Challenges: Bridging Insurance Gaps for MDD Innovations

EP. 8 Depression Treatment: Expert Guide to Medication Management & Therapeutic Success

EP. 8 Depression Treatment: Expert Guide to Medication Management & Therapeutic Success

EP. 9 From Neuroplasticity to Patient Conversations: Managing Affective Disorders Effectively

EP. 9 From Neuroplasticity to Patient Conversations: Managing Affective Disorders Effectively

EP. 10 Managing Persistent MDD: Case Studies and Treatment Challenges

EP. 10 Managing Persistent MDD: Case Studies and Treatment Challenges

EP. 11 Evaluating Treatment Failure and Symptomatic Remission in MDD

EP. 11 Evaluating Treatment Failure and Symptomatic Remission in MDD

EP. 12 Exploring Rapid-Acting Therapies in MDD: Pharmacodynamics and Treatment Evolution

EP. 12 Exploring Rapid-Acting Therapies in MDD: Pharmacodynamics and Treatment Evolution

EP. 13 Addressing Unsatisfactory Responses in Chronic MDD

EP. 13 Addressing Unsatisfactory Responses in Chronic MDD

EP. 14 Defining and Managing Treatment-Resistant Depression: Efficacy and Real-World Insights

EP. 14 Defining and Managing Treatment-Resistant Depression: Efficacy and Real-World Insights

EP. 15 Optimizing Treatment Response: Insights from Clinical Data and Real-World Experience

EP. 15 Optimizing Treatment Response: Insights from Clinical Data and Real-World Experience

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

Experts featured in this series.

Multidisciplinary Approaches to Long-Term Narcolepsy Care

ByKarl Doghramji, MD, FAASM, DFAPA,Michael Strunc, MD,Ellen Wermter, FNP-BC, DBSM, FAASM,W. Christopher Winter, MD

April 22nd 2026

Experts featured in this series.

Optimizing Narcolepsy Treatment Through Polypharmacy

ByKarl Doghramji, MD, FAASM, DFAPA,Michael Strunc, MD,Ellen Wermter, FNP-BC, DBSM, FAASM,W. Christopher Winter, MD

April 15th 2026

Experts featured in this series.

Assessing DEA Scheduling and Emerging Therapies in Narcolepsy

ByKarl Doghramji, MD, FAASM, DFAPA,Michael Strunc, MD,Ellen Wermter, FNP-BC, DBSM, FAASM,W. Christopher Winter, MD

April 15th 2026

Experts featured in this series.

Evaluating Pitolisant and Other Pharmacologic Treatment Options for Narcolepsy

ByKarl Doghramji, MD, FAASM, DFAPA,Michael Strunc, MD,Ellen Wermter, FNP-BC, DBSM, FAASM,W. Christopher Winter, MD

April 8th 2026

Experts featured in this series.

Narcolepsy Treatment Considerations in Pediatric Patients

ByKarl Doghramji, MD, FAASM, DFAPA,Michael Strunc, MD,Ellen Wermter, FNP-BC, DBSM, FAASM,W. Christopher Winter, MD

April 8th 2026

Latest CME

Southern California Psychiatry Conference

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Trending on Psychiatric Times

Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD

Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD

ALTO-203, an H3 Inverse Agonist, in Depression: Biomarker and Pharmacodynamic Findings

Addressing Sexual Wellness: A Psychiatric Perspective

What Do Orexin-2 Receptor Agonists Mean for Psychiatry?